ArticleHepatology international2023

Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial.

Fan Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.